{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:25:58Z","timestamp":1775539558128,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG18387"],"award-info":[{"award-number":["IG18387"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00277-018-3351-4","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T17:29:22Z","timestamp":1525454962000},"page":"2001-2003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine"],"prefix":"10.1007","volume":"97","author":[{"given":"Greta","family":"Scapinello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Vio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitja","family":"Nabergoj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Visentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Martines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bonaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livio","family":"Trentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianpietro","family":"Semenzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"issue":"17","key":"3351_CR1","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1182\/blood-2015-11-624312","volume":"127","author":"L Arcaini","year":"2016","unstructured":"Arcaini L, Rossi D, Paulli M (2016) Splenic marginal zone lymphoma: from genetics to management. Blood 127(17):2072\u20132081","journal-title":"Blood"},{"issue":"20","key":"3351_CR2","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390","journal-title":"Blood"},{"issue":"2","key":"3351_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cancergencyto.2004.04.026","volume":"156","author":"CL Andersen","year":"2005","unstructured":"Andersen CL, Gruszka-Westwood A, Atkinson S, Matutes E, Catovsky D, Pedersen RK, Pedersen BB, Pulczynski S, Hokland P, Jacobsen E, Koch J (2005) Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization. Cancer Genet Cytogenet 156(2):122\u2013128","journal-title":"Cancer Genet Cytogenet"},{"issue":"9","key":"3351_CR4","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","volume":"116","author":"M Salido","year":"2010","unstructured":"Salido M, Baro C, Oscier D, Stamatopoulos K, Dierlamm J, Matutes E, Traverse-Glehen A, Berger F, Felman P, Thieblemont C, Gesk S, Athanasiadou A, Davis Z, Gardiner A, Milla F, Ferrer A, Mollejo M, Calasanz MJ, Florensa L, Espinet B, Luno E, Wlodarska I, Verhoef G, Garcia-Granero M, Salar A, Papadaki T, Serrano S, Piris MA, Sole F (2010) Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the splenic B-cell lymphoma group. Blood 116(9):1479\u20131488","journal-title":"Blood"},{"key":"3351_CR5","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1182\/asheducation.V2012.1.426.3798535","volume":"2012","author":"PL Zinzani","year":"2012","unstructured":"Zinzani PL (2012) The many faces of marginal zone lymphoma. Hematol Am Soc Hematol Educ Program 2012:426\u2013432","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1\u20132","key":"3351_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.beha.2016.09.005","volume":"30","author":"MA Piris","year":"2017","unstructured":"Piris MA, Onaindia A, Mollejo M (2017) Splenic marginal zone lymphoma. Best Pract Res Clin Haematol 30(1\u20132):56\u201364","journal-title":"Best Pract Res Clin Haematol"},{"issue":"3","key":"3351_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12308-011-0124-6","volume":"5","author":"Rebecca Sonu","year":"2011","unstructured":"Sonu R, Gregg J, Chen M (2012) Splenic marginal zone lymphoma with t(8;14)(q24.1;q32)\/MYC rearrangement. J Hematop (5):141\u20137","journal-title":"Journal of Hematopathology"},{"issue":"11","key":"3351_CR8","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.humpath.2012.01.003","volume":"43","author":"D Hoehn","year":"2012","unstructured":"Hoehn D, Miranda RN, Kanagal-Shamanna R, Lin P, Medeiros LJ (2012) Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation. Hum Pathol 43(11):1828\u20131838","journal-title":"Hum Pathol"},{"issue":"1\u20132","key":"3351_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.beha.2016.09.004","volume":"30","author":"V Spina","year":"2017","unstructured":"Spina V, Rossi D (2017) Molecular pathogenesis of splenic and nodal marginal zone lymphoma. Best Pract Res Clin Haematol 30(1\u20132):5\u201312","journal-title":"Best Pract Res Clin Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3351-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3351-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3351-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T10:31:49Z","timestamp":1571308309000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3351-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["3351"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3351-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]},"assertion":[{"value":"13 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The consent to publication of the material was previously obtained. The principles of the Declaration of Helsinki were followed. The Padua Region Ethic Committee approved the work (n. 4089\/AO17). Data are available at the Department of Medicine, Padua University Hospital, Division of Hematology, Surgical Pathology, Radiology, and at the Istituto Oncologico Veneto (IOV), Division of Cytodiagnostics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}